Galliprant® (grapiprant tablets) for Dogs
Treat canine osteoarthritis (OA) inflammation and pain at home with a once-daily chewable tablet.
Approved for use in dogs older than 9 months of age and greater than 8 lbs.
Galliprant Keeps Dogs Moving
Treats Canine Osteoarthritis Inflammation and Pain
Galliprant is a first-of-its-kind NSAID for dogs that features a unique mode of action, targeting the EP4 receptor, effectively addressing inflammation and pain.
Once-Daily Chewable Tablet
The pork-flavored chewable tablet is simple to administer, and it can be given with or without food, making it easy to fit into your dog’s daily routine.
Shown to be Safe & Effective for Long-Term Use*
Vet-Recommended and FDA-approved, Galliprant is shown to be safe for daily use and formulated to have a reduced impact on your dog's organ health.1
* Monitoring is recommended if used long-term
Talk To Your Vet
Approved for use in dogs 9 months of age and older, and 8lbs and greater. Ask your veterinarian if Galliprant is right for your dog.
What is canine osteoarthritis?
OA is a painful and progressive disease that causes inflammation and swelling in a dog’s joints.
How do you know if your dog has canine osteoarthritis? Look for the following symptoms:
- Slowing down
- Limping
- Hip swaying
- Bunny hopping
- Difficulty with stairs
- Struggling to get up
If your dog shows any of these warning signs, schedule an appointment with your vet.
Treating canine osteoarthritis inflammation and pain earlier can improve long-term outlook , and OA management is most effective when started early.2
Osteoarthritis in younger dogs is more common than you may think. In fact, 40% of dogs 4 years of age and younger had radiographic signs of OA.3
Find a vet near you to see if Galliprant is right for your dog >>
Save When Purchasing Galliprant®
Get $20 off of 30 tablets and $60 off of 90 tablets.
Use the code GPT2026 to claim your rebate.
Indication
Galliprant controls pain and inflammation associated with osteoarthritis in dogs.
Important Safety Information
For use in dogs only. Keep this and all medications out of reach of children and pets to prevent accidental ingestion or overdose. Galliprant is a non-COX inhibiting NSAID. As a class, NSAIDs may be associated with gastrointestinal, kidney and liver side effects. Evaluation for pre-existing conditions and regular monitoring are recommended. Do not use in dogs that have a hypersensitivity to grapiprant. Concomitant use of Galliprant with other NSAIDs or corticosteroids should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. Owners should be advised to observe for signs of potential drug toxicity. Adverse reactions may include vomiting, diarrhea, decreased appetite, watery or bloody stools, and decreases in serum albumin and total protein. Please see product label for full prescribing information.
